MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Ocugen Inc/

Recent news which mentions Ocugen Inc/

Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
Tickers INNO
Tags Ocugen Inc/ Insurance Cabaletta Bio Inc/
From Business Journals
Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds
Tickers INNO
Tags Biotech Carisma Therapeutics Pharmaceuticals
From Business Journals
Lab Notes: Wedgewood Pharmacy acquires Colorado lab; Aprea Therapeutics raises $5.5M
Tickers INNO
Tags Marcy A/ Bliss Insurance Michael Travis
From Business Journals
Lab Notes: Drexel and Bancroft team up to advance autism research; AmerisourceBergen forms new partnership
Tickers INNO
Tags Health Care Quan A/ Vu Drexel University
From Business Journals
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
Tickers INNO
Tags Shankar Musunuri Medical Devices Christopher von Jako
From Business Journals
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
Tickers INNO
Tags Passage Bio Inc/ Biotech Jolly Mazumdar
From Business Journals
Lab Notes: Cabaletta signs licensing deal for up to $162M; merger unites life sciences tech providers
Tickers INNO
Tags Roundup Georg Schett Cabaletta Bio, Inc/
From Business Journals
Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding
Tickers INNO
Tags Insurance Benjamin Doranz Jon T/ Holmlund
From Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
Tags Shankar Musunuri Ocugen Inc/ Insurance
From Business Journals
Lab Notes: Endo gets U.S. rights to potential knee pain drug; Optinose stock climbs after positive study results
Tickers INNO
Tags Health Care Insurance Ramy Mahmoud
From Business Journals
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech
Tags Coronavirus Biotech Ocugen Inc/
From Business Journals
Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat
Tags Ocugen Inc/ Insurance Pharmaceuticals
From Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
Tickers INNO
Tags Shankar Musunuri Medical Devices Insurance
From Business Journals
Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice
Tickers INNO
Tags Roundup Inno Tim Crew
From Business Journals
Ocugen's stock plummets after FDA rejects emergency use bid for Covid vaccine
Tags Health Care Biotech Coronavirus
From Business Journals
Ocugen expects $53.5M from stock sale amid efforts to bring Covaxin to the U.S.
Tags Coronavirus Health Care Biotech
From Business Journals
Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant
Tags Ocugen Inc/ Shankar Musunuri Pharmaceuticals
From Business Journals
Lab Notes: Strata Skin Sciences makes acquisition; Cabaletta Bio promotes 2 executives
Tickers INNO
Tags Gwendolyn Binder Arun Das MBF Therapeutics
From Business Journals
Lab Notes: Trevena advances new pain drug; Ocugen receives good news from FDA
Tickers INNO
Tags Insurance Saar Gill Trevena Inc/
From Business Journals
FDA places a hold on Ocugen's plan for U.S. trials of the Covid-19 vaccine Covaxin
Tags Ocugen Inc/ Pharmaceuticals Insurance
From Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
Tags Coronavirus Biotech Shankar Musunuri
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
Tickers INNO
Tags Insurance Trice Medical, Inc/ Inovio Pharmaceuticals Inc/
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story